Correction: Zinc oxide nanoparticle chelated phosphocreatine-grafted chitosan composite hydrogels for enhancing osteogenesis and angiogenesis in bone regeneration - Top-Institutions - MDSpire

Correction: Zinc oxide nanoparticle chelated phosphocreatine-grafted chitosan composite hydrogels for enhancing osteogenesis and angiogenesis in bone regeneration

  • By

  • Leidong Lian

  • Dingli Xu

  • Chaonan He

  • Zhe Luo

  • Han Yu

  • Botao Liu

  • Ke Zhou

  • Liangjie Lu

  • Kaifeng Gan

  • June 10, 2026

  • 0 min

Share

Top Institutions in Orthopedic Medicine

Brief introduction explaining scope and methodology.

  • #1

    Hospital for Special Surgery
    Hospital for Special Surgery

    New York, New York

    Key Differentiators

    • Orthopedics
    • Regenerative Medicine

  • #2

    NYU Langone Hospitals
    NYU Langone Hospitals

    New York, New York

    Key Differentiators

    • Orthopedics
    • Regenerative Medicine

  • #3

    CÚRAM, Science Foundation Ireland Research Centre for Medical Devices
    CÚRAM, Science Foundation Ireland Research Centre for Medical Devices

    Galway, Ireland

    Key Differentiators

    • Medical Devices
    • Regenerative Medicine

  • #4

    Fundação para a Ciência e Tecnologia (FCT, Portugal)
    Fundação para a Ciência e Tecnologia (FCT, Portugal)

    Lisbon, Portugal

    Key Differentiators

    • Research Funding
    • Biomedical Research

  • #5

    University of Ottawa
    University of Ottawa

    Ottawa, Ontario

    Key Differentiators

    • Medical Research
    • Orthopedics

Original Source(s)

Correction: Zinc oxide nanoparticle chelated phosphocreatine-grafted chitosan composite hydrogels for enhancing osteogenesis and angiogenesis in bone regeneration

  • by Leidong Lian, Dingli Xu, Chaonan He, Zhe Luo, Han Yu, Botao Liu, Ke Zhou, Liangjie Lu, Kaifeng Gan

  • June 10, 2026

Related Content

BCOR-CCNB3 fusion–positive sarcoma treated with chemotherapy and carbon-ion radiotherapy: a case report of long-term disease control of a cervical spine case with a 12-year follow-up

CAA Use Tied to Higher Arthroplasty Risk

In a UK cohort, patients with osteoarthritis who initiated centrally acting analgesics had a higher hazard of knee or hip replacement than those who initiated SSRIs, though residual confounding by pain severity remains a key limitation.

Identification and management of unrecognized femoral head epiphysiolysis: a case report